_id
6919ec433c536f8df23183d9
Ticker
OPTI.LSE
Name
OptiBiotix Health Plc
Exchange
LSE
Address
Innovation Centre, York, United Kingdom, YO10 5DG
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://optibiotix.com
Description
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential health benefits. Its products include Slimbiome, which offers a scientifically supported, non-pharmaceutical approach to reduce hunger and cravings; CholBiome, a food supplement for reducing cholesterol and blood pressure and supporting vascular health; and Sweetbiotix which are dietary fibres used as an alternative to sugar and existing sweeteners. The company also provides WellBiome a novel in vitro model of the human gut; OptiBiotics, a portfolio of prebiotics developed to target and enhance the growth of specific probiotics; and SlimBiome X3, a supplement that helps users cut calories without hunger and cravings. The company was formerly known as Ducat Ventures PLC and changed its name to OptiBiotix Health Plc in August 2014. OptiBiotix Health Plc was incorporated in 2006 and is headquartered in York, the United Kingdom.
Last Close
67500
Volume
312496
Current Price
6.47
Change
0
Last Updated
2025-12-30T11:20:20.806Z
Image
https://logo.clearbit.com/optibiotix.com
Ipo Date
-
Market Cap
6972770
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
557000
Cost Of Revenue
254000
Gross Profit
303000
Operating Expenses
1740000
Operating Income
-1437000
Interest Expense
-
Pretax Income
-1183000
Net Income
-1177000
Eps
-0.011496645973192303
Dividends Per Share
-
Shares Outstanding
103300304
Income Tax Expense
6000
EBITDA
-1335000
Operating Margin
-257.98922800718134
Total Other Income Expense Net
254000
Cash
1299000
Short Term Investments
-
Receivables
407000
Inventories
394000
Total Current Assets
2121000
Property Plant Equipment
-
Total Assets
9152000
Payables
460000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
732000
Equity
8420000
Bs_currency_symbol
GBP
Depreciation
102000
Change In Working Capital
-138000
Cash From Operations
-895000
Capital Expenditures
0
Cash From Investing
742000
Cash From Financing
713000
Net Change In Cash
560000
Cf_currency_symbol
-
PE
-
PB
78.66788859263657
ROE
-13.978622327790974
ROA
-12.860576923076922
FCF
-895000
Fcf Percent
-1.606822262118492
Piotroski FScore
1
Health Score
27
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2.5
Growth Investing Score
1.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
557000
Quarters > 0 > income Statement > cost Of Revenue
254000
Quarters > 0 > income Statement > gross Profit
303000
Quarters > 0 > income Statement > operating Expenses
1740000
Quarters > 0 > income Statement > operating Income
-1437000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-1183000
Quarters > 0 > income Statement > net Income
-1177000
Quarters > 0 > income Statement > eps
-0.011496645973192303
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
102377685
Quarters > 0 > income Statement > income Tax Expense
6000
Quarters > 0 > income Statement > EBITDA
-1335000
Quarters > 0 > income Statement > operating Margin
-257.98922800718134
Quarters > 0 > income Statement > total Other Income Expense Net
254000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
1299000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
407000
Quarters > 0 > balance Sheet > inventories
394000
Quarters > 0 > balance Sheet > total Current Assets
2121000
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
9152000
Quarters > 0 > balance Sheet > payables
460000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
732000
Quarters > 0 > balance Sheet > equity
8420000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-1177000
Quarters > 0 > cash Flow > depreciation
102000
Quarters > 0 > cash Flow > change In Working Capital
-138000
Quarters > 0 > cash Flow > cash From Operations
-895000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
742000
Quarters > 0 > cash Flow > cash From Financing
713000
Quarters > 0 > cash Flow > net Change In Cash
560000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.011496645973192303
Quarters > 0 > ratios > PB
78.66788859263657
Quarters > 0 > ratios > ROE
-13.978622327790974
Quarters > 0 > ratios > ROA
-12.860576923076922
Quarters > 0 > ratios > FCF
-895000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-1.606822262118492
Quarters > 0 > health Score
27
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
594000
Quarters > 1 > income Statement > cost Of Revenue
477000
Quarters > 1 > income Statement > gross Profit
117000
Quarters > 1 > income Statement > operating Expenses
1317000
Quarters > 1 > income Statement > operating Income
-1200000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
933000
Quarters > 1 > income Statement > net Income
986000
Quarters > 1 > income Statement > eps
0.010067063283775372
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
97943161
Quarters > 1 > income Statement > income Tax Expense
-53000
Quarters > 1 > income Statement > EBITDA
1268000
Quarters > 1 > income Statement > operating Margin
-202.02020202020202
Quarters > 1 > income Statement > total Other Income Expense Net
2133000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
739000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
433000
Quarters > 1 > balance Sheet > inventories
230000
Quarters > 1 > balance Sheet > total Current Assets
1423000
Quarters > 1 > balance Sheet > property Plant Equipment
0
Quarters > 1 > balance Sheet > total Assets
9045000
Quarters > 1 > balance Sheet > payables
270000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
647000
Quarters > 1 > balance Sheet > equity
8398000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
986000
Quarters > 1 > cash Flow > depreciation
103000
Quarters > 1 > cash Flow > change In Working Capital
44000
Quarters > 1 > cash Flow > cash From Operations
-1022999
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
498000
Quarters > 1 > cash Flow > cash From Financing
1000
Quarters > 1 > cash Flow > net Change In Cash
-524000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.010067063283775372
Quarters > 1 > ratios > PB
75.45751984639199
Quarters > 1 > ratios > ROE
11.740890688259109
Quarters > 1 > ratios > ROA
10.901050304035378
Quarters > 1 > ratios > FCF
-1022999
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-1.7222205387205387
Quarters > 1 > health Score
60
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
276000
Quarters > 2 > income Statement > cost Of Revenue
271000
Quarters > 2 > income Statement > gross Profit
5000
Quarters > 2 > income Statement > operating Expenses
1071000
Quarters > 2 > income Statement > operating Income
-1066000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-2681000
Quarters > 2 > income Statement > net Income
-2791000
Quarters > 2 > income Statement > eps
-0.029548149402896587
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
94456000
Quarters > 2 > income Statement > income Tax Expense
-8000
Quarters > 2 > income Statement > EBITDA
-2575000
Quarters > 2 > income Statement > operating Margin
-386.231884057971
Quarters > 2 > income Statement > total Other Income Expense Net
-1733000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
1263000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
414000
Quarters > 2 > balance Sheet > inventories
258000
Quarters > 2 > balance Sheet > total Current Assets
1935000
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
8030000
Quarters > 2 > balance Sheet > payables
313000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
665000
Quarters > 2 > balance Sheet > equity
7365000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-2791000
Quarters > 2 > cash Flow > depreciation
106000
Quarters > 2 > cash Flow > change In Working Capital
130000
Quarters > 2 > cash Flow > cash From Operations
-745000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
89000
Quarters > 2 > cash Flow > cash From Financing
1284000
Quarters > 2 > cash Flow > net Change In Cash
628000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.029548149402896587
Quarters > 2 > ratios > PB
82.97764019008825
Quarters > 2 > ratios > ROE
-37.89545145960624
Quarters > 2 > ratios > ROA
-34.7571606475716
Quarters > 2 > ratios > FCF
-745000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-2.699275362318841
Quarters > 2 > health Score
27
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
293000
Quarters > 3 > income Statement > cost Of Revenue
131000
Quarters > 3 > income Statement > gross Profit
162000
Quarters > 3 > income Statement > operating Expenses
1097000
Quarters > 3 > income Statement > operating Income
-935000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-189000
Quarters > 3 > income Statement > net Income
-193000
Quarters > 3 > income Statement > eps
-0.00209552556432612
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
92101000
Quarters > 3 > income Statement > income Tax Expense
4000
Quarters > 3 > income Statement > EBITDA
-303000
Quarters > 3 > income Statement > operating Margin
-319.1126279863481
Quarters > 3 > income Statement > total Other Income Expense Net
746000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
635000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
460000
Quarters > 3 > balance Sheet > inventories
188000
Quarters > 3 > balance Sheet > total Current Assets
1380000
Quarters > 3 > balance Sheet > property Plant Equipment
0
Quarters > 3 > balance Sheet > total Assets
9404000
Quarters > 3 > balance Sheet > payables
56000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
532000
Quarters > 3 > balance Sheet > equity
8872000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-193000
Quarters > 3 > cash Flow > depreciation
113000
Quarters > 3 > cash Flow > change In Working Capital
-138000
Quarters > 3 > cash Flow > cash From Operations
-941000
Quarters > 3 > cash Flow > capital Expenditures
15000
Quarters > 3 > cash Flow > cash From Investing
683000
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-258000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.00209552556432612
Quarters > 3 > ratios > PB
67.16563007213706
Quarters > 3 > ratios > ROE
-2.1753832281334535
Quarters > 3 > ratios > ROA
-2.0523181624840494
Quarters > 3 > ratios > FCF
-956000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-3.262798634812287
Quarters > 3 > health Score
26
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
870000
Annuals > 0 > income Statement > cost Of Revenue
539000
Annuals > 0 > income Statement > gross Profit
331000
Annuals > 0 > income Statement > operating Expenses
2597000
Annuals > 0 > income Statement > operating Income
-2266000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-1866000
Annuals > 0 > income Statement > net Income
-1805000
Annuals > 0 > income Statement > eps
-0.01843679548842115
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
97902046
Annuals > 0 > income Statement > income Tax Expense
-61000
Annuals > 0 > income Statement > EBITDA
-2057000
Annuals > 0 > income Statement > operating Margin
-260.4597701149425
Annuals > 0 > income Statement > total Other Income Expense Net
400000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
739000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
433000
Annuals > 0 > balance Sheet > inventories
230000
Annuals > 0 > balance Sheet > total Current Assets
1423000
Annuals > 0 > balance Sheet > property Plant Equipment
0
Annuals > 0 > balance Sheet > total Assets
9045000
Annuals > 0 > balance Sheet > payables
270000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
647000
Annuals > 0 > balance Sheet > equity
8398000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-2266000
Annuals > 0 > cash Flow > depreciation
209000
Annuals > 0 > cash Flow > change In Working Capital
174000
Annuals > 0 > cash Flow > cash From Operations
-1768000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
587000
Annuals > 0 > cash Flow > cash From Financing
1285000
Annuals > 0 > cash Flow > net Change In Cash
104000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.01843679548842115
Annuals > 0 > ratios > PB
80.32211204334365
Annuals > 0 > ratios > ROE
-21.49321266968326
Annuals > 0 > ratios > ROA
-19.955776672194585
Annuals > 0 > ratios > FCF
-1768000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-2.032183908045977
Annuals > 0 > health Score
26
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
644000
Annuals > 1 > income Statement > cost Of Revenue
324000
Annuals > 1 > income Statement > gross Profit
320000
Annuals > 1 > income Statement > operating Expenses
2015000
Annuals > 1 > income Statement > operating Income
-1695000
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-2043000
Annuals > 1 > income Statement > net Income
-2039000
Annuals > 1 > income Statement > eps
-0.022607577252719228
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
90191000
Annuals > 1 > income Statement > income Tax Expense
-4000
Annuals > 1 > income Statement > EBITDA
-1838000
Annuals > 1 > income Statement > operating Margin
-263.19875776397515
Annuals > 1 > income Statement > total Other Income Expense Net
-348000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
635000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
460000
Annuals > 1 > balance Sheet > inventories
188000
Annuals > 1 > balance Sheet > total Current Assets
1380000
Annuals > 1 > balance Sheet > property Plant Equipment
0
Annuals > 1 > balance Sheet > total Assets
9404000
Annuals > 1 > balance Sheet > payables
56000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
532000
Annuals > 1 > balance Sheet > equity
8872000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-2039000
Annuals > 1 > cash Flow > depreciation
205000
Annuals > 1 > cash Flow > change In Working Capital
-47000
Annuals > 1 > cash Flow > cash From Operations
-1527000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
1110000
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-417000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.022607577252719228
Annuals > 1 > ratios > PB
70.04237939585211
Annuals > 1 > ratios > ROE
-22.982416591523897
Annuals > 1 > ratios > ROA
-21.682262866865166
Annuals > 1 > ratios > FCF
-1527000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-2.37111801242236
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
457000
Annuals > 2 > income Statement > cost Of Revenue
213000
Annuals > 2 > income Statement > gross Profit
244000
Annuals > 2 > income Statement > operating Expenses
2732000
Annuals > 2 > income Statement > operating Income
-2489000
Annuals > 2 > income Statement > interest Expense
5013000
Annuals > 2 > income Statement > pretax Income
2441000
Annuals > 2 > income Statement > net Income
2587000
Annuals > 2 > income Statement > eps
0.027753639513801723
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
93213000
Annuals > 2 > income Statement > income Tax Expense
-146000
Annuals > 2 > income Statement > EBITDA
2748000
Annuals > 2 > income Statement > operating Margin
-544.6389496717725
Annuals > 2 > income Statement > total Other Income Expense Net
4930000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
1052000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
627000
Annuals > 2 > balance Sheet > inventories
178000
Annuals > 2 > balance Sheet > total Current Assets
1857000
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
11548000
Annuals > 2 > balance Sheet > payables
191000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
0
Annuals > 2 > balance Sheet > total Liabilities
643000
Annuals > 2 > balance Sheet > equity
10905000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-2489000
Annuals > 2 > cash Flow > depreciation
224000
Annuals > 2 > cash Flow > change In Working Capital
1021000
Annuals > 2 > cash Flow > cash From Operations
-1109000
Annuals > 2 > cash Flow > capital Expenditures
168000
Annuals > 2 > cash Flow > cash From Investing
-331000
Annuals > 2 > cash Flow > cash From Financing
485000
Annuals > 2 > cash Flow > net Change In Cash
-955000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
0.027753639513801723
Annuals > 2 > ratios > PB
58.893862448418155
Annuals > 2 > ratios > ROE
23.723062815222377
Annuals > 2 > ratios > ROA
22.402147558018704
Annuals > 2 > ratios > FCF
-1277000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-2.7943107221006565
Annuals > 2 > health Score
66
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
2213000
Annuals > 3 > income Statement > cost Of Revenue
1090000
Annuals > 3 > income Statement > gross Profit
1123000
Annuals > 3 > income Statement > operating Expenses
2489000
Annuals > 3 > income Statement > operating Income
-1365000
Annuals > 3 > income Statement > interest Expense
48000
Annuals > 3 > income Statement > pretax Income
6177000
Annuals > 3 > income Statement > net Income
6261000
Annuals > 3 > income Statement > eps
0.06553550494054597
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
95536000
Annuals > 3 > income Statement > income Tax Expense
-84000
Annuals > 3 > income Statement > EBITDA
6513000
Annuals > 3 > income Statement > operating Margin
-61.680976050610035
Annuals > 3 > income Statement > total Other Income Expense Net
7542000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
2007448
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
1743739
Annuals > 3 > balance Sheet > inventories
101877
Annuals > 3 > balance Sheet > total Current Assets
3853064
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
20144663
Annuals > 3 > balance Sheet > payables
419948
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
819359
Annuals > 3 > balance Sheet > total Liabilities
1972263
Annuals > 3 > balance Sheet > equity
18136618
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-1365314
Annuals > 3 > cash Flow > depreciation
288455
Annuals > 3 > cash Flow > change In Working Capital
-742397
Annuals > 3 > cash Flow > cash From Operations
-1564661
Annuals > 3 > cash Flow > capital Expenditures
193506
Annuals > 3 > cash Flow > cash From Investing
-193506
Annuals > 3 > cash Flow > cash From Financing
2900936
Annuals > 3 > cash Flow > net Change In Cash
1142768
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
0.06553550494054597
Annuals > 3 > ratios > PB
36.29359343621837
Annuals > 3 > ratios > ROE
34.52132034759733
Annuals > 3 > ratios > ROA
31.08019230701452
Annuals > 3 > ratios > FCF
-1758167
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
-0.794472209670131
Annuals > 3 > health Score
66
Valuation > metrics > PE
-0.011496645973192303
Valuation > metrics > PB
78.66788859263657
Valuation > final Score
20
Valuation > verdict
2522.3% Overvalued
Profitability > metrics > ROE
-13.978622327790974
Profitability > metrics > ROA
-55.49269212635549
Profitability > metrics > Net Margin
-2.1131059245960504
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.08693586698337293
Risk > metrics > Interest Coverage
-9.453947368421053
Risk > final Score
22
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.610869565217391
Liquidity > metrics > Quick Ratio
3.7543478260869567
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
83
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
46
Prev Risks > 1
20
Prev Risks > 2
27
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:03:09.640Z
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential health benefits. Its products include Slimbiome, which offers a scientifically supported, non-pharmaceutical approach to reduce hunger and cravings; CholBiome, a food supplement for reducing cholesterol and blood pressure and supporting vascular health; and Sweetbiotix which are dietary fibres used as an alternative to sugar and existing sweeteners. The company also provides WellBiome a novel in vitro model of the human gut; OptiBiotics, a portfolio of prebiotics developed to target and enhance the growth of specific probiotics; and SlimBiome X3, a supplement that helps users cut calories without hunger and cravings. The company was formerly known as Ducat Ventures PLC and changed its name to OptiBiotix Health Plc in August 2014. OptiBiotix Health Plc was incorporated in 2006 and is headquartered in York, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AOptiBiotix Health PLC (LSE:OPTI) Strengthens Investor Access Through FTSE All Share Digital Kalkine Media
Read more →Showing 2 of 7
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of OptiBiotix Health Plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.